The Impact of the Novel Sodium-Dependent Glucose Cotransporter 2 Inhibitor, Enavogliflozin, on Cardiac Reverse Remodeling in Heart Failure Patients With Type 2 Diabetes Mellitus: A Case Series.
Ontology highlight
SUBMITTER: Yang T
PROVIDER: S-EPMC11538723 | biostudies-literature | 2024 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA